Article
Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients.
European journal of clinical pharmacology - 1 Jan 2013
Han Nayoung, Yun Hwi-yeol, Hong Jin-yi, Kim In-Wha, Ji Eunhee, Hong Su Hyun, Kim Yon Su, Ha Jongwon, Shin Wan Gyoon, Oh Jung Mi
Abstract excerpt
PURPOSE: Tacrolimus is a commonly used immunosuppressant in solid organ transplantation recipients, but it is characterized by a narrow therapeutic range and large inter-individual variability. The purpose of this study was to establish a population pharmacokinetic (PK) model of tacrolimus and evaluate the influence of clinical covariates, including the genetic polymorphisms of the cytochrome P450 3A5 gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
